Scott D. Grimes - Apr 19, 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Apr 19, 2022
Transactions value $
-$205,269
Form type
4
Date filed
4/21/2022, 05:03 PM
Previous filing
Apr 7, 2022
Next filing
May 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale -$205K -4.1K -1.65% $50.09 244K Apr 19, 2022 Direct F1, F2
holding CDLX Common Stock 55.8K Apr 19, 2022 See Footnote F3
holding CDLX Common Stock 53.1K Apr 19, 2022 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended September 15, 2021.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F4 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.